PGHH · NSE
Procter & Gamble Hygiene and Health Care Limited
₹7,486
-1.67% (-₹127)
Prev. close
₹7,613
Volume
66,505
Delivery %
63.7%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Details
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Mr. Kumar Venkatasubramanian
Headquarters
Mumbai
Employees
386
Website
in.pg.comExchange
View on NSE ↗Key stats
Market cap
₹24,300.11 Cr
P/E ratio (TTM)
30.7
Dividend yield
1.58%
EPS (TTM)
₹243.62
Beta (1Y · daily vs NIFTY 50)
0.33
Beta (5Y · monthly vs NIFTY 50)
0.64
Shares float
94.30 L
EPS · quarter ended Jun 2026
₹38.90
Upcoming earnings
05 Nov 2026
Financial Performance
01 · Financials
Revenue for Jun 2021–Jun 2021 is as filed with BSE (standalone), and the first plotted growth figure is computed against Jun 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 2.9% on Jun 2022. FY21 growth needs FY20 filings, which the data source doesn't provide. Net income and EBITDA are omitted from this chart: coverage begins inside the plotted window, and every plotted period must carry a complete point set — the P&L table below has the available figures. Fiscal year-end moved from June to March between Jun 2024 and Mar 2025; the company's transition period bridged the two calendars, so no intermediate 12-month year exists — the "missing" column is a period that never was, not a data gap.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ₹3,574.14 Cr | ₹3,792.45 Cr | ₹3,905.21 Cr | ₹4,191.57 Cr | — | ₹4,290.42 Cr | |
| EBITDA | ₹923.66 Cr | ₹854.21 Cr | ₹909.21 Cr | ₹1,022.70 Cr | — | ₹1,213.51 Cr |
| ₹651.79 Cr | ₹575.75 Cr | ₹678.14 Cr | ₹675.02 Cr | — | ₹856.50 Cr | |
| Diluted EPS | ₹200.79 | ₹177.37 | ₹208.91 | ₹207.95 | — | ₹263.86 |
This company moved its fiscal year-end; the transition period bridged the two calendars, so no intermediate 12-month year exists between the adjacent columns.
Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Pretax income, Tax provision, Interest expense, Other income, Diluted EPS have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ₹1,632.71 Cr | ₹1,682.57 Cr | ₹2,137.32 Cr | ₹1,858.56 Cr | ₹1,754.73 Cr | ₹1,803.54 Cr | |
| ₹3.47 Cr | ₹5.10 Cr | ₹4.03 Cr | ₹3.08 Cr | — | ₹87.00 L | |
| Stockholders' equity | ₹714.27 Cr | ₹737.57 Cr | ₹946.03 Cr | ₹774.86 Cr | ₹736.99 Cr | ₹753.47 Cr |
This company moved its fiscal year-end; the transition period bridged the two calendars, so no intermediate 12-month year exists between the adjacent columns.
Trade receivables, Cash & equivalents, CWIP, Others, Total debt, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ₹863.12 Cr | ₹573.10 Cr | ₹825.77 Cr | ₹470.53 Cr | ₹593.21 Cr | ₹924.08 Cr | |
| Investing cash flow | ₹6.94 Cr | ₹-26.85 Cr | ₹-9.91 Cr | ₹1.06 Cr | ₹-34.28 Cr | ₹11.37 Cr |
| ₹-1,106.43 Cr | ₹-568.94 Cr | ₹-477.01 Cr | ₹-861.75 Cr | ₹-666.23 Cr | ₹-844.80 Cr | |
| Capital expenditure | — | ₹-49.80 Cr | ₹-44.44 Cr | ₹-44.68 Cr | ₹-55.03 Cr | ₹-49.54 Cr |
| End cash position | ₹647.67 Cr | ₹624.98 Cr | ₹963.83 Cr | ₹573.67 Cr | ₹466.37 Cr | ₹557.02 Cr |
This company moved its fiscal year-end; the transition period bridged the two calendars, so no intermediate 12-month year exists between the adjacent columns.
Depreciation & amortization, Change in working capital, Dividends paid, Capital expenditure have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 21–Jun 26(20Q) |
|---|---|
| Promoter | 70.64% |
| Public | 29.36% |
| Employee trusts | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Consumer Defensive
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Hindustan Unilever Limited | ₹4.56 L Cr | ₹1,932 | 43.7 | 9.36 | 30.9% | 0.03 | +5.3% | -25.3% |
| ITC Limited | ₹3.34 L Cr | ₹262.3 | 16.8 | 4.60 | 28.5% | 0.03 | +4.8% | -36.3% |
| Nestle India Limited | ₹2.67 L Cr | ₹1,383.3 | 69.9 | 66.52 | 80.0% | 0.29 | +19.6% | +14.1% |
| Avenue Supermarts Limited | ₹2.42 L Cr | ₹3,749.9 | 79.4 | 9.89 | 12.1% | 0.10 | +16.0% | -21.2% |
| Varun Beverages Limited | ₹1.41 L Cr | ₹421.95 | 41.5 | 7.18 | 15.5% | 0.13 | +7.1% | -10.9% |
| Britannia Industries Limited | ₹1.20 L Cr | ₹4,982 | 45.7 | 23.58 | 49.6% | 0.27 | +7.5% | -18.3% |
| Marico Limited | ₹1.06 L Cr | ₹803.9 | 56.0 | 25.19 | 41.9% | 0.13 | +26.2% | +11.7% |
| TATA CONSUMER PRODUCTS LIMITED | ₹98,978.89 Cr | ₹1,013.7 | 60.4 | 4.54 | 7.1% | 0.13 | +15.2% | -10.8% |
| United Spirits Limited | ₹98,697.70 Cr | ₹1,371 | 58.5 | 11.02 | 20.5% | 0.05 | +7.8% | +3.3% |
| Godrej Consumer Products Limited | ₹89,334.52 Cr | ₹880 | 46.6 | 7.06 | 14.7% | 0.35 | +8.5% | -28.9% |
| Dabur India Limited | ₹67,765.15 Cr | ₹384.55 | 34.7 | 5.93 | 16.6% | 0.11 | +5.2% | -28.1% |
| Procter & Gamble Hygiene and Health Care Limited | ₹24,712.36 Cr | ₹7,486 | 31.3 | 32.80 | 113.7% | 0.00 | +2.1% | -43.9% |
Ranked by market cap within Consumer Defensive, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 30
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
1 index
Weight is a free-float market-cap-share estimate from NSE’s live index data, not NSE’s own published (and sometimes capped) index weight. Indices without a live weight feed are listed without one, in alphabetical order after the weighted ones.
Dividend stocks: Jindal Drilling, Procter & Gamble, Suprajit Engg, Maharashtra Seamless to turn ex-date today
Procter & Gamble Hygiene and Health Care Ltd. shares will trade ex-dividend today, September 1, for a final dividend of Rs 60 per share. Today is also the record date for determining eligible shareholders for this dividend. The payment is scheduled for October 6.
Rs 153 dividend payout: Last to buy Procter & Gamble Hygiene, CCL Products and 15 other stocks ahead of September 1 ex-date
Procter & Gamble Hygiene and Health Care shares will turn ex-dividend on September 1, 2026, for a final dividend of Rs 60 per share. This is the highest dividend among 17 companies going ex-dividend on that date, with a combined payout of Rs 153 per share. Investors must buy shares before the ex-date to be eligible for the dividend.